Ekso Bionics Holdings Inc (EKSO) - Total Liabilities

Latest as of March 2026: $13.93 Million USD

Based on the latest financial reports, Ekso Bionics Holdings Inc (EKSO) has total liabilities worth $13.93 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ekso Bionics Holdings Inc - Total Liabilities Trend (2011–2025)

This chart illustrates how Ekso Bionics Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See Ekso Bionics Holdings Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Ekso Bionics Holdings Inc Competitors by Total Liabilities

The table below lists competitors of Ekso Bionics Holdings Inc ranked by their total liabilities.

Company Country Total Liabilities
Ananda Development Public Company Limited
BK:ANAN
Thailand ฿17.27 Billion
Transcontinental Inc
TO:TCL-B
Canada CA$1.37 Billion
Ymc Co. Ltd
KQ:155650
Korea ₩55.40 Billion
01 Communique Laboratory Inc
V:ONE
Canada CA$333.45K
FOODWELL Co. Ltd
KQ:005670
Korea ₩131.62 Billion
Opnet Technologies Co Ltd
TWO:8034
Taiwan NT$137.78 Million
Legacy Iron Ore Ltd
AU:LCY
Australia AU$9.03 Million
Assems Inc.
KQ:136410
Korea ₩44.32 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Ekso Bionics Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Ekso Bionics Holdings Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.55 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.71 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ekso Bionics Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ekso Bionics Holdings Inc (2011–2025)

The table below shows the annual total liabilities of Ekso Bionics Holdings Inc from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 $11.08 Million -20.52%
2024-12-31 $13.95 Million -14.51%
2023-12-31 $16.31 Million +5.50%
2022-12-31 $15.46 Million +29.41%
2021-12-31 $11.95 Million -26.08%
2020-12-31 $16.16 Million +6.91%
2019-12-31 $15.12 Million +1.28%
2018-12-31 $14.93 Million -10.06%
2017-12-31 $16.60 Million -7.25%
2016-12-31 $17.89 Million -23.50%
2015-12-31 $23.39 Million +119.13%
2014-12-31 $10.67 Million +75473.49%
2013-12-31 $14.12K 0.00%
2012-12-31 $14.12K +74.37%
2011-12-31 $8.10K --

About Ekso Bionics Holdings Inc

NASDAQ:EKSO USA Medical Instruments & Supplies
Market Cap
$42.05 Million
Market Cap Rank
#22667 Global
#4913 in USA
Share Price
$11.80
Change (1 day)
+0.00%
52-Week Range
$2.82 - $12.95
All Time High
$148.05
About

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It … Read more